Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PRMT6-IN-3

Product Specifications

UNSPSC Description

PRMT6-IN-3 (compound 25) is a selective PRMT6 inhibitor with an IC50 value of 192 nM. PRMT6-IN-3 can induce apoptosis in cancer cells and has anticancer activity[1].

Target Antigen

Apoptosis; Histone Methyltransferase

Type

Reference compound

Related Pathways

Apoptosis;Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/prmt6-in-3.html

Solubility

DMSO : 55 mg/mL (ultrasonic;warming)

Smiles

O=S(C1CC1)(NC2=CC=C(C3=CC(CN(C)CCNC)=CN=C3)C=C2)=O

Molecular Weight

374.50

References & Citations

[1]Qiangsheng Zhang, et al. Design, synthesis and evaluation of antitumor activity of selective PRMT6 inhibitors. Eur J Med Chem. 2022 Dec 20;247:115032.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-152236/PRMT6-IN-3-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-152236/PRMT6-IN-3-SDS-MedChemExpress.pdf

Clinical Information

No Development Reported

CAS Number

2890765-10-1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

CA7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
14853061 1.0 µg DNA

CA7 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

Ask
View Details
PLS2 Polyclonal Antibody
E44H08664 100ul

PLS2 Polyclonal Antibody

Ask
View Details
Anti-CD3E (otelixizumab biosimilar) mAb
MBS1881513-01 0.05 mg

Anti-CD3E (otelixizumab biosimilar) mAb

Ask
View Details
Anti-CD3E (otelixizumab biosimilar) mAb
MBS1881513-02 0.1 mg

Anti-CD3E (otelixizumab biosimilar) mAb

Ask
View Details
Anti-CD3E (otelixizumab biosimilar) mAb
MBS1881513-03 5x 0.1 mg

Anti-CD3E (otelixizumab biosimilar) mAb

Ask
View Details
COX2 Antibody
R30815 100 µg

COX2 Antibody

Ask
View Details